{"id":"probucol-group","safety":{"commonSideEffects":[{"rate":null,"effect":"QT prolongation"},{"rate":null,"effect":"Gastrointestinal disturbances"},{"rate":null,"effect":"Xanthomas regression"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Probucol lowers serum cholesterol through inhibition of cholesterol synthesis and increased fecal excretion of cholesterol and bile acids. It also acts as a potent antioxidant, preventing the oxidation of low-density lipoprotein (LDL), which is thought to reduce atherosclerosis progression and improve endothelial function.","oneSentence":"Probucol is a lipophilic antioxidant that reduces cholesterol levels and prevents LDL oxidation.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:02:49.711Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypercholesterolemia"},{"name":"Atherosclerosis prevention"}]},"trialDetails":[{"nctId":"NCT06931834","phase":"","title":"Expanded Access Program for R007 (Probucol) Tablets in Adults With Mitochondrial Disease and Chronic Kidney Disease","status":"AVAILABLE","sponsor":"RiboNova Inc.","startDate":"","conditions":"Mitochondrial Disease, Chronic Kidney Disease","enrollment":""},{"nctId":"NCT00823849","phase":"PHASE4","title":"Study of Cilostazol and Probucol to Assess Their Effects on Atherosclerosis Related Biomarker","status":"COMPLETED","sponsor":"Otsuka Beijing Research Institute","startDate":"2008-10","conditions":"Type 2 Diabetes Mellitus, Arteriosclerosis Obliterans","enrollment":200},{"nctId":"NCT06604117","phase":"","title":"Efficacy of Probucol Combined with Statins Treatment for Ischemic Stroke","status":"RECRUITING","sponsor":"Xuanwu Hospital, Beijing","startDate":"2024-10-17","conditions":"Ischemic Stroke, Atherosclerosis of Artery, Lipid Disorder","enrollment":200},{"nctId":"NCT03753555","phase":"PHASE4","title":"The Effect of InTensive Statin in Ischemic Stroke With inTracranial Atherosclerotic Plaques","status":"RECRUITING","sponsor":"General Hospital of Shenyang Military Region","startDate":"2018-12-01","conditions":"Stroke, Ischemic, Atherosclerosis, Cerebral","enrollment":100},{"nctId":"NCT06225752","phase":"PHASE3","title":"Probucol for Symptomatic Intracranial and Extracranial Artery Stenosis","status":"RECRUITING","sponsor":"First Affiliated Hospital of Wannan Medical College","startDate":"2024-06-15","conditions":"Ischemic Stroke, TIA","enrollment":5452},{"nctId":"NCT01142284","phase":"PHASE2","title":"Evaluation of Concomitant Administration of Cilostazol and Probucol on Biomarkers, Endothelial Function and Safety","status":"COMPLETED","sponsor":"Korea Otsuka Pharmaceutical Co., Ltd.","startDate":"2010-05-19","conditions":"Peripheral Artery Disease","enrollment":80},{"nctId":"NCT01000467","phase":"PHASE4","title":"Pharmacokinetics Study for Probucol","status":"COMPLETED","sponsor":"Korea Otsuka Pharmaceutical Co., Ltd.","startDate":"2009-02","conditions":"Healthy","enrollment":30},{"nctId":"NCT01291641","phase":"PHASE4","title":"Effect of Probucol and/or Cilostazol on Mean IMT in Patients With Coronary Heart dIsease","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2011-03","conditions":"Hyperlipidemias","enrollment":342},{"nctId":"NCT01726816","phase":"PHASE2","title":"Efficacy and Safety Study of Probucol in Patients With Diabetic Nephropathy","status":"COMPLETED","sponsor":"Korea Otsuka Pharmaceutical Co., Ltd.","startDate":"2012-10","conditions":"Diabetic Nephropathy","enrollment":126},{"nctId":"NCT01013532","phase":"PHASE4","title":"PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage","status":"UNKNOWN","sponsor":"Asan Medical Center","startDate":"2009-06","conditions":"Brain Ischemia, Intracranial Hemorrhages","enrollment":1600},{"nctId":"NCT02196805","phase":"NA","title":"A Bioequivalence Study Comparing a Single Oral Intake of an Imported PROBUCOL Tablet(Lorelco) With a Marketed PROBUCOL Tablet(Chang Tai) in Chinese Healthy Volunteers","status":"COMPLETED","sponsor":"Otsuka Beijing Research Institute","startDate":"2009-03","conditions":"Chinese Healthy Volunteers","enrollment":120},{"nctId":"NCT01590901","phase":"PHASE1","title":"Pharmacokinetics and Safety Study of Probucol by Multiple Administration in Healthy Male Subjects","status":"COMPLETED","sponsor":"Otsuka Beijing Research Institute","startDate":"2012-02","conditions":"Healthy","enrollment":12},{"nctId":"NCT01031667","phase":"PHASE4","title":"Synergistic Effect of Combination Therapy With Cilostazol and Probucol on Plaque Stabilization and Lesion Regression: Serial Intravascular Ultrasound and Virtual Histology Study(SECURE Study)","status":"COMPLETED","sponsor":"Yonsei University","startDate":"2009-11","conditions":"Therapy","enrollment":118},{"nctId":"NCT00823875","phase":"PHASE4","title":"Study of Cilostazol and Probucol Alone and in Combination on Atherosclerosis Related Biomarker---atherosclerosis Cerebral Infarction Patient as Study Subject","status":"COMPLETED","sponsor":"Otsuka Beijing Research Institute","startDate":"2009-03","conditions":"Atherosclerosis Cerebral Infarction","enrollment":200}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":79,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Changtai"],"phase":"marketed","status":"active","brandName":"Probucol group","genericName":"Probucol group","companyName":"Otsuka Beijing Research Institute","companyId":"otsuka-beijing-research-institute","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Probucol is a lipophilic antioxidant that reduces cholesterol levels and prevents LDL oxidation. Used for Hypercholesterolemia, Atherosclerosis prevention.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}